Shopping Cart
- Remove All
- Your shopping cart is currently empty
Calhex 231 hydrochloride is a CaSR inhibitor with potential for diabetic cardiomyopathy treatment; it blocks Ca2+-induced accumulation of [3H]inositol phosphate with an IC50 of 0.39 μM in HEK293 cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $88 | 5 days | |
5 mg | $148 | 5 days |
Description | Calhex 231 hydrochloride is a CaSR inhibitor with potential for diabetic cardiomyopathy treatment; it blocks Ca2+-induced accumulation of [3H]inositol phosphate with an IC50 of 0.39 μM in HEK293 cells. |
Targets&IC50 | CaSR:0.39 μM |
In vitro | Calhex 231 could inhibit Itch (atrophin-1 interacting protein 4)-ubiquitin proteasome and TGF-β1/Smads pathways, and then depress the proliferation of cardiac fibroblasts, along with the reduction deposition of collagen, alleviate glucose-induced myocardial fibrosis. Calhex 231 treatment significantly downregulates the CaSR, α-SMA, Col-I/III, MMP2/9 expresses. Calhex231 alleviates high glucose-induced myocardial fibrosis in cardiac fibroblasts [1]. |
In vivo | In the type 1 diabetic model (T1D) rats, Calhex 231 (4.07 mg/kg; i.p.; daily; for 12 weeks; male Wistar rats) treatment ameliorates diabetic myocardial fibrosis [1]. |
Molecular Weight | 443.41 |
Formula | C25H28Cl2N2O |
Cas No. | 2387505-78-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.